GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,000 | +23.5% | 13 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -19.0% | 13 | 0.0% | 0.00% | – |
| Q1 2022 | $21,000 | -22.2% | 13 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -98.9% | 13 | -98.0% | 0.00% | – |
| Q3 2021 | $2,491,000 | +21.3% | 642 | 0.0% | 0.00% | – |
| Q2 2021 | $2,054,000 | -82.1% | 642 | -87.9% | 0.00% | – |
| Q1 2021 | $11,468,000 | -26.3% | 5,285 | -23.9% | 0.00% | – |
| Q4 2020 | $15,557,000 | -30.9% | 6,945 | -17.6% | 0.00% | – |
| Q3 2020 | $22,505,000 | +484.7% | 8,429 | +570.0% | 0.00% | – |
| Q2 2020 | $3,849,000 | -84.2% | 1,258 | -89.9% | 0.00% | – |
| Q1 2020 | $24,422,000 | +47.1% | 12,460 | +114.7% | 0.00% | – |
| Q4 2019 | $16,599,000 | +10.3% | 5,804 | +41.6% | 0.00% | – |
| Q3 2019 | $15,043,000 | +4273.0% | 4,099 | +4838.6% | 0.00% | – |
| Q2 2019 | $344,000 | -73.3% | 83 | -78.4% | 0.00% | – |
| Q1 2015 | $1,286,000 | -71.5% | 384 | -57.2% | 0.00% | – |
| Q3 2014 | $4,512,000 | – | 897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |